Wyden Demands Answers from Pfizer Over Lyrica Price Increases
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., called on drug maker Pfizer to justify to the public the continuous price increases it has taken on its drug Lyrica, which is taken by millions of Americans and costs Medicare $2.1 billion every year. “Seniors are paying too much for prescription drugs, threatening […]
Wyden Reveals Opioid Industry Ties on HHS Task Force, Probes Advocacy Group’s Finances
In Separate Letter to U.S. Pain Foundation, Wyden Questions Ties Between Group’s Patient Assistance Program and Embattled Opioid Maker Insys Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today renewed his efforts to shine a light on financial ties between opioid manufacturers, third-party advocacy groups, and government panels that provide outside expertise […]
Wyden Measure Ensures Student Loan Debt Won’t Keep Recent Graduates From Saving for Retirement
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today rolled out legislation to give working Americans the flexibility to save for the future while having enough money to make their student loan repayments. Wyden’s introduction is in preparation for next year when it is expected that broader conversations on how to improve […]
Wyden Statement on Ruling that Affordable Care Act is Unconstitutional
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement after a Texas District Court judge ruled against the Affordable Care Act, threatening core parts of the law like pre-existing condition protections, tax credits for health care and the Medicaid expansion: “Today’s ruling is an assault on all Americans’ basic health care rights […]
Wyden Statement on Vote to Overturn Treasury’s Pro-Dark Money Rule
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today delivered a statement on the Senate floor ahead of a vote on his resolution with Senator Jon Tester, D-Mont., to overturn a Treasury ruling that shields the identities of large dark money donors from U.S. tax authorities. “The Trump administration’s dark money rule […]
Wyden Statement at Finance Committee Hearing to Consider the Nomination of Courtney Dunbar Jones to Serve as a Judge on the United States Tax Court
Before we get to the subject of this morning’s hearing, I’d like to briefly touch on another matter. As this is likely our last committee hearing before the end of this Congress, let me begin by saying that it has been a privilege to work closely with Chairman Hatch on this committee over the past […]
Wyden Floor Statement on the Nomination of Muzinich to Serve as Deputy Treasury Secretary and the Trump Tax Scam
M. President, the Senate will soon cast the first procedural vote on the nomination of Justin Muzinich to serve as the deputy secretary of the Treasury. I’m going to oppose this nomination, and I’d like to lay out exactly why, beginning with this basic rule I’m going to maintain going forward: If a nominee says […]
Wyden Recognizes Bipartisan Health Care Accomplishments, Charts Next Steps on Chronic Care
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today spoke at the Bipartisan Policy Center to honor the leadership of retiring Finance Committee Chairman Orrin Hatch, R-Utah, on the passage of the CHRONIC Care Act, and to offer ideas on additional improvements that could be made to update the Medicare guarantee for […]
Wyden. Grassley Announce Bill to Recoup Millions from Pharma Ripoff
After EpiPen Maker Overcharged Taxpayers for Hundreds of Millions of Dollars, Bipartisan Senators Release Legislation to Clamp Down on Misclassification Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and senior Finance Committee member Chuck Grassley, R-Iowa, today introduced a bill that would fix an issue in Medicaid that has allowed pharmaceutical manufacturers […]
Wyden Statement on Signing of NAFTA Update
WASHINGTON—Senator Ron Wyden, D-Ore., the ranking member of the Senate Finance Committee, released the following statement on the signing today of an updated NAFTA agreement with Canada and Mexico: “While there are elements of the revised NAFTA agreement that are clear improvements over the status quo and could set welcome new standards in international trade, […]